Aker BioMarine AS reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was USD 335.3 million compared to USD 277.2 million a year ago. Net loss was USD 9 million compared to net income of USD 10 million a year ago.

Basic loss per share from continuing operations was USD 0.1 compared to basic earnings per share from continuing operations of USD 0.11 a year ago. Diluted loss per share from continuing operations was USD 0.1 compared to diluted earnings per share from continuing operations of USD 0.11 a year ago.